Axitinib in the Metastic Treatment Renal Cancer
| dc.contributor.author | Richter Igor | cs |
| dc.contributor.author | Dvořák Josef | cs |
| dc.contributor.author | Hejzlarová Věra | cs |
| dc.contributor.author | Bartoš Jiří | cs |
| dc.date.accessioned | 2018-09-25T12:18:33Z | |
| dc.date.available | 2018-09-25T12:18:33Z | |
| dc.date.issued | 2017-01-01 | cs |
| dc.format.extent | 0 | cs |
| dc.identifier.uri | https://dspace.tul.cz/handle/15240/31833 | |
| dc.language.iso | cze | cs |
| dc.relation.ispartofseries | 0 | cs |
| dc.subject | renal cancer | cs |
| dc.subject | treatment toxicity | cs |
| dc.subject | overall survival | cs |
| dc.subject | survival | cs |
| dc.title | Axitinib in the Metastic Treatment Renal Cancer | en |
| dc.title | Axitinib V Léčbě Metastatického Renálního Karcinomu | cs |
| local.identifier.publikace | 5302 |